News / Africa

New Meningitis Vaccine a Success in Chad

A child receives a meningitis vaccination at the community center in El Daein, East Darfur, Sudan on October 8, 2012.
A child receives a meningitis vaccination at the community center in El Daein, East Darfur, Sudan on October 8, 2012.
Jennifer Lazuta
— A study published this month in the Lancet medical journal found a new meningitis vaccine being used in Chad reduced the incidence of the disease by 94 percent.  According to the World Health Organization, meningitis affects nearly half a billion people living in sub-Saharan Africa each year and, even with proper treatment, is often deadly. 
 
Researchers say the first meningitis vaccine developed specifically for Africa has “dramatically reduced” the number of cases of the disease in Chad, as well as prevented its spread.
 
Dr. James Stuart, a professor at the London School of Hygiene and Tropical Medicine and a co-author of the study, said his team looked at the effects of what is known as MenAfriVac on 1.8 million people under the age of 29 across three regions in Chad during the 2012 meningitis epidemic.
 
"What we found was that the number of cases dropped dramatically in the part of the country that was vaccinated and that the meningitis epidemic continued in the part of the country that had not been vaccinated," Stuart said.  "So this, although it was not a trial, suggested that the vaccine had a very positive effect on protecting people against meningitis."

Stuart said MenAfriVac, which targets the type-A strain of the disease, completely prevented type A in all of the vaccinated regions.  It also reduced the incidence of all types of meningitis.  
 
According to the World Health Organization, more than one million cases of meningitis, which is the inflammation of the protective tissue that covers the brain and spinal cord, have been reported in Africa since 1988.
 
The highest incidence of the disease occurs in what is known as the “meningitis belt” of sub-Saharan Africa, a strip of 25 countries stretching from Senegal in the west to Ethiopia in the east.
 
No other meningitis vaccines have proven to be as effective as MenAfriVac, Stuart said.
 
"The new vaccine seems to stop people carrying the germ and it stops it therefore from being transmitted, whereas the old vaccine did not have an effect on carriage, so it did not stop the germ being transmitted between people," he said.  "So this new vaccine therefore has a double effect.  One is that it gives you a good individual protection against meningitis, and at the same time, it is actually stopping transmission, so it is actually preventing other people from getting meningitis as well."

Stuart said that such prevention is key when it comes to meningitis, as the disease can spread quickly, passing from person to person via bacteria that live in the throat.  Outbreaks in sub-Saharan Africa are common and have killed as many as 25,000 people at a time.
 
While this particular vaccine is not new, it was licensed in India in 2009 and introduced in Burkina Faso, Mali and Niger in December 2010, this was the first time researchers were able to test its effectiveness.

The World Health Organization says antibiotics are available as treatment, but meningitis can lead to serious health problems once contracted, including seizures, deafness, paralysis and brain damage, and that it results in death in about 10 percent of reported cases.  In Chad, the mortality rate has risen as high as 75 percent during outbreaks.
 
Stuart said that MenAfriVac will sell for less than 50 cents per dose in sub-Saharan Africa and can be included as part of routine preventative vaccinations for children.
 
While its longterm effects are still being studied, Stuart said there have been no indications of negative side effects.
 
Following its success in Chad, MenAfriVac has since been used to vaccinate an additional 100 million people against type A meningitis in sub-Saharan Africa.  Stuart said plans are underway to roll out the vaccine in the rest of the meningitis belt countries.

You May Like

EU Court Fines Poland for Hosting CIA 'Black Sites'

Ruling is first time a court has acknowledged suspects were held and tortured at the sites, under US program launched following the 9/11 terrorist attacks More

Migrant Issues Close to Home Spur Groups to Take Action

Groups placing water, food in the desert, or aiding detainees after release, have one common goal: no more deaths of migrants crossing illegally into the US More

Video At AIDS Conference, Prevention Pill Stirs Excitement

Truveda shows promise, spurring debate over access and other approaches More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Treatment for Childhood Epilepsy Heats up Medical Marijuana Debatei
X
Shelley Schlender
July 24, 2014 6:43 PM
In the United States, marijuana is classed as an illegal drug by the federal government. But nearly half the states have legalized it, to some degree. Proponents say some strains of marijuana might have exceptional health benefits, for treating pain or inflammation in chronic conditions such as cancer, multiple sclerosis and epilepsy. Shelley Schlender reports on a strain of medical marijuana developed in Colorado that is reputed to reduce seizures in childhood epilepsy
Video

Video Treatment for Childhood Epilepsy Heats up Medical Marijuana Debate

In the United States, marijuana is classed as an illegal drug by the federal government. But nearly half the states have legalized it, to some degree. Proponents say some strains of marijuana might have exceptional health benefits, for treating pain or inflammation in chronic conditions such as cancer, multiple sclerosis and epilepsy. Shelley Schlender reports on a strain of medical marijuana developed in Colorado that is reputed to reduce seizures in childhood epilepsy
Video

Video Airbus Adds Metal 3D Printed Parts to New Jets

By the end of this year, European aircraft manufacturing consortium Airbus plans to deliver the first of its new, extra-wide-body passenger jets, the A350-XWB. Among other technological innovations, the new plane will also incorporate metal parts made in a 3-D printer. VOA's George Putic has more.
Video

Video Death Toll From Israel-Gaza Conflict Surpasses 700

Gaza officials say a shelling hit a compound housing a United Nations-run school in the Gaza Strip, killing more than a dozen people, during an Israeli offensive in the area. Heavy fighting between the Israeli military and Hamas militants continued on Thursday, pushing up the death toll. So far, more than 730 Palestinians and 35 Israelis have been killed in the conflict. VOA's Scott Bobb has the latest from Jerusalem.
Video

Video AIDS Conference Welcomes Exciting Developments in HIV Treatment, Prevention

Significant strides have been made in recent years toward the treatment and prevention of HIV, the virus that causes AIDS. This year, at the International AIDS Conference, the AIDS community welcomed progress on a new pill that may prevent transmission of the deadly virus. VOA’s Anita Powell reports from Melbourne, Australia.
Video

Video Israel Targets Gaza Supply Tunnels

The Israeli military has launched a ground operation in Gaza to destroy the myriad tunnels that may have been used to smuggle weapons to Hamas. VOA's Zlatica Hoke reports that could mean more hardship for the people of Gaza, who obtain some of their essential supplies through these underground passages
Video

Video Researchers Target Low-Cost Avatar Technology

Scientists at the University of Southern California Institute for Creative Technologies say 3-dimensional representations could revolutionize social media. Elizabeth Lee has more from Los Angeles.
Video

Video IAEA: Iran Turns its Enriched Uranium Into Less Harmful Form

Iran has converted its stockpiles of enriched uranium into a less dangerous form that is more difficult to use for nuclear weapons, according to the United Nations’ Atomic Energy Agency. The move complies with an interim deal reached with Western powers on Iran's nuclear program last year, in exchange for easing of sanctions. Henry Ridgwell reports for VOA from London.
Video

Video In Cambodia, HIV Diagnosis Brings Deadly Shame

Although HIV/AIDS is now a treatable condition, a positive diagnosis is still a life altering experience. In Cambodia, people living with HIV are often disowned by friends, family and the community. This humiliation can be unbearable. We bring you one Cambodian woman’s struggle to overcome a life tragedy and her own HIV positive diagnosis.

AppleAndroid